Charles River Labs (CRL) CEO Event Cancellation Insignificant - Sterne Agee

Charles River Labs' (NYSE: CRL) CEO James Foster's cancellation at today's Barclays conference is not likely to be significant, said Sterne Agee analyst Greg Bolan. The cancellation may have created some speculation among investors, but it now appears the CEO simply had to attend a last minute event. Bolan was scheduled to present today at 9.30am.

Sterne Agee has a Buy rating on Charles River Labs (NYSE: CRL) with a price target of $71.00

For an analyst ratings summary and ratings history on Charles River Labs click here. For more ratings news on Charles River Labs click here.

Shares of Charles River Labs closed at $58.05 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Charles River to provide NGS services for Arovella cancer therapy
• Freedom Broker Upgrades Aehr Test Systems (AEHR) to Buy
• Datadog (DDOG) PT Raised to $315 at UBS